A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

CRISPR technology has revolutionized genetic testing and disease detection, offering precise, rapid, and cost-effective diagnostic solutions. This gene-editing tool has been adapted for molecular ...